Suggest - Finance

Have you bought any mutual funds this year or late last year while the market was doing its skyrocket thin

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

g? Last year it was hard to lose money. This year it has been easy.

You should be calling your mutual fun

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

(they all have 800 numbers) to find out if and when they plan to pay their capital gains and dividends.

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

You might say to yourself, they won't be paying anything this year because the fund is selling for less no

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

than it did at the beginning of the year. Think again. It is very probable that the mutual fund manager t

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ok profits on many high flyers that he bought cheap last year. According to the way funds are set up those

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

profits are taxable to holders of the mutual fund and not to the fund itself.

It is possible you bought

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

fund at $40 per share that is now selling at $30 per share and be hit with a 25% capital gains distributi

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

on of $10. On paper you now have a $10 per share loss and a tax bill based on the $10 per share distributi

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

n. That is adding injury to insult.

With this as a possible scenario it might be prudent to sell your fun

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

for less than you paid for it. You should work the numbers with your accountant to see if this might redu

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ce your tax bill. But you have to do it now. You can't wait until after the mutual fund declares its capit

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

l gains distribution. This is especially true if you have purchased any high tech or international funds d

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

uring the past year. You can carry losses forward to next year to offset against profits and distributions

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

next year.

The greatest numbers of mutual funds declare these distributions near the end of the year, usu

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

lly starting in November with most of them in December. The rumors I hear are that the distributions will

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

be early this year because of the poor performance of the majority of funds.

This applies to everyone who

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

does not have a tax shelter of some kind such as a 401k, IRA, SEP or other similar investment vehicle.

On

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

e piece of advice I want you to heed. Don't buy any mutual funds now because they are "cheap". Wait until

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

fter they declare their capital gains and dividend distributions. You could be whacked with a big tax bill

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.suggest.org.ua/article/118114/suggest-Investment-Capital-Gains.html">Investment Capital Gains</a>

BB link (for phorums):
[url=http://www.suggest.org.ua/article/118114/suggest-Investment-Capital-Gains.html]Investment Capital Gains[/url]

Losing business you don't even know exists is common in any business start-up. I see Internet marketers who throw up their one page website and sell only one product....

Cashback and rewards credit cards are a much better alternative to store issued cards. Many retailers who issue their store-specific cards tell you about the 10% off you will receive on your first purchase, but neglect to tell you about the actual card terms.

The first thing you need to know when you decide to trade shares by joining an online trading of stocks system is to visit the websites of the best online trading brokers available. These companies offer a wide variety of market flow previsions and developments in the online trading of stock futures. When you decide to open an account, you must know that this is generally free of charge, but you have to pay every time you engage in a stock or security bonds transaction.

Tags

Links

Suggest - Investment Capital Gains

Related Articles: